Cancer research
Silibinin Enhances Anti-PD-1 Efficacy in Brain Metastases of Non-Small Cell Lung Cancer
Research at the Dr. Josep Trueta University Hospital in Catalonia, Spain, has uncovered a promising combination therapy for non-small cell lung cancer (NSCLC) patients with brain metastases (BM). The study, published in Frontiers in Medicine, demonstrates that silibinin, a flavonolignan with known blood-brain barrier permeability and anti-BM activity, can enhance